Corrigendum: Effective Anti-tumor Response by TIGIT Blockade Associated With FcγR Engagement and Myeloid Cell Activation

Corrigendum: Effective Anti-tumor Response by TIGIT Blockade Associated With FcγR Engagement and Myeloid Cell Activation

Bibliographic Details
Main Authors:	Jin-Hwan Han, Mingmei Cai, Jeffery Grein, Samanthi Perera, Hongmei Wang, Mike Bigler, Roenna Ueda, Thomas W. Rosahl, Elaine Pinheiro, Drake LaFace, Wolfgang Seghezzi, Sybil M. Genther Williams
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2020-11-01
Series:	Frontiers in Immunology
Subjects:	TIGIT FcγR myeloid cells combination cancer immunotherapy costimulatory molecules immune checkpoint blockade
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2020.615755/full

Similar Items

Effective Anti-tumor Response by TIGIT Blockade Associated With FcγR Engagement and Myeloid Cell Activation
by: Jin-Hwan Han, et al.
Published: (2020-10-01)

TIGIT blockade enhances functionality of peritoneal NK cells with altered expression of DNAM-1/TIGIT/CD96 checkpoint molecules in ovarian cancer
by: Ralph Ja Maas, et al.
Published: (2020-01-01)

Addition of anti-TIM3 or anti-TIGIT Antibodies to anti-PD1 Blockade Augments Human T cell Adoptive Cell Transfer
by: Marina Martinez, et al.
Published: (2021-01-01)

TIGIT/CD226 Axis Regulates Anti-Tumor Immunity
by: Jinah Yeo, et al.
Published: (2021-02-01)

TIGIT-Fc as a Potential Therapeutic Agent for Fetomaternal Tolerance
by: Wenyan Fu, et al.
Published: (2021-03-01)

TIGIT Blockade: A Multipronged Approach to Target the HIV Reservoir
by: Kayla A. Holder, et al.
Published: (2020-05-01)

Intrinsic Expression of Immune Checkpoint Molecule TIGIT Could Help Tumor Growth in vivo by Suppressing the Function of NK and CD8+ T Cells
by: Xiu-Man Zhou, et al.
Published: (2018-11-01)

Targeting TIGIT for Immunotherapy of Cancer: Update on Clinical Development
by: Anand Rotte, et al.
Published: (2021-09-01)

TIGIT and PD1 Co-blockade Restores ex vivo Functions of Human Tumor-Infiltrating CD8+ T Cells in Hepatocellular CarcinomaSummary
by: Zhouhong Ge, et al.
Published: (2021-01-01)

Long-term aspirin intervention can inhibit TIGIT, regulating T cells to reverse damage to intestines
by: Xiaojuan Yang, et al.
Published: (2021-01-01)

Dynamic Expressions of TIGIT on Splenic T Cells and TIGIT-Mediated Splenic T Cell Dysfunction of Mice With Chronic Toxoplasma gondii Infection
by: Haoran Li, et al.
Published: (2021-08-01)

Targeting the TIGIT-PVR immune checkpoint axis as novel therapeutic option in breast cancer
by: Hauke Stamm, et al.
Published: (2019-12-01)

Expression of the immune checkpoint receptor TIGIT in Hodgkin’s lymphoma
by: Wenchao Li, et al.
Published: (2018-12-01)

TIGIT and PD-1 dual checkpoint blockade enhances antitumor immunity and survival in GBM
by: Alice L. Hung, et al.
Published: (2018-08-01)

Tim-3 signaling blockade with α-lactose induces compensatory TIGIT expression in Plasmodium berghei ANKA-infected mice
by: Yiwei Zhang, et al.
Published: (2019-11-01)

Expression of TIGIT in splenic and circulatory T cells from mice acutely infected with Toxoplasma gondii
by: Wang Shuai, et al.
Published: (2021-01-01)

CD8+CD122+PD-1+ Tregs Synergize With Costimulatory Blockade of CD40/CD154, but Not B7/CD28, to Prolong Murine Allograft Survival
by: Huazhen Liu, et al.
Published: (2019-02-01)

TIGIT enhances CD4+ regulatory T‐cell response and mediates immune suppression in a murine ovarian cancer model
by: Fengzhen Chen, et al.
Published: (2020-05-01)

Computer-aided design of PVR mutants with enhanced binding affinity to TIGIT
by: Xiaowen Zhou, et al.
Published: (2021-02-01)

A TIGIT-based chimeric co-stimulatory switch receptor improves T-cell anti-tumor function
by: Shiran Hoogi, et al.
Published: (2019-09-01)

Imbalance of the CD226/TIGIT Immune Checkpoint Is Involved in the Pathogenesis of Primary Biliary Cholangitis
by: Chuiwen Deng, et al.
Published: (2020-07-01)

TIGIT Induces (CD3+) T Cell Dysfunction in Colorectal Cancer by Inhibiting Glucose Metabolism
by: Qi Shao, et al.
Published: (2021-09-01)

Successful Treatment of T Cell-Mediated Acute Rejection with Delayed CTLA4-Ig in Mice
by: James S. Young, et al.
Published: (2017-09-01)

Belatacept Does Not Inhibit Follicular T Cell-Dependent B-Cell Differentiation in Kidney Transplantation
by: Gretchen N. de Graav, et al.
Published: (2017-05-01)

TIGIT-uttryck som prognostisk markör vid prostatacancer : En immunohistokemisk utvärdering av T cell immunoreceptor with Ig and ITIM domains-uttryck i primärtumören hos prostatacancerpatienter med eller utan lymfkörtelmetastas
by: Ähdel, Fredrik
Published: (2021)

Repositioning liothyronine for cancer immunotherapy by blocking the interaction of immune checkpoint TIGIT/PVR
by: Xiuman Zhou, et al.
Published: (2020-09-01)

Overexpression of TIGIT in NK and T Cells Contributes to Tumor Immune Escape in Myelodysplastic Syndromes
by: Fanqiao Meng, et al.
Published: (2020-08-01)

TIGIT and PD-1 Immune Checkpoint Pathways Are Associated With Patient Outcome and Anti-Tumor Immunity in Glioblastoma
by: Itay Raphael, et al.
Published: (2021-05-01)

Clinical Remission of Sight-Threatening Non-Infectious Uveitis Is Characterized by an Upregulation of Peripheral T-Regulatory Cell Polarized Towards T-bet and TIGIT
by: Rose M. Gilbert, et al.
Published: (2018-05-01)

TIGIT expressing CD4+T cells represent a tumor-supportive T cell subset in chronic lymphocytic leukemia
by: Kemal Catakovic, et al.
Published: (2018-01-01)

Expression of the Inhibitory Receptor TIGIT Is Up-Regulated Specifically on NK Cells With CD226 Activating Receptor From HIV-Infected Individuals
by: Xiaowan Yin, et al.
Published: (2018-10-01)

Deficiency of host CD96 and PD-1 or TIGIT enhances tumor immunity without significantly compromising immune homeostasis
by: Heidi Harjunpää, et al.
Published: (2018-07-01)

Checkpoint Receptor TIGIT Expressed on Tim-1+ B Cells Regulates Tissue Inflammation
by: Sheng Xiao, et al.
Published: (2020-07-01)

Analysis of the Characteristics of TIGIT-Expressing CD3−CD56+NK Cells in Controlling Different Stages of HIV-1 Infection
by: Xin Zhang, et al.
Published: (2021-02-01)

PD-1 and TIGIT Are Highly Co-Expressed on CD8+ T Cells in AML Patient Bone Marrow
by: Ling Xu, et al.
Published: (2021-08-01)

HTLV-1 bZIP Factor Impairs Anti-viral Immunity by Inducing Co-inhibitory Molecule, T cell Immunoglobulin and ITIM Domain (TIGIT).
by: Yasuma, Keiko
Published: (2016)

Commentary: Belatacept Does Not Inhibit Follicular T Cell-Dependent B-Cell Differentiation in Kidney Transplantation
by: Paul M. Schroder, et al.
Published: (2017-11-01)

Enhanced antitumor efficacy of a novel oncolytic vaccinia virus encoding a fully monoclonal antibody against T-cell immunoglobulin and ITIM domain (TIGIT)
by: Shuguang Zuo, et al.
Published: (2021-02-01)

Blimp-1 impairs T cell function via upregulation of TIGIT and PD-1 in patients with acute myeloid leukemia
by: Liuluan Zhu, et al.
Published: (2017-06-01)

TIGIT+ TIM-3+ NK cells are correlated with NK cell exhaustion and disease progression in patients with hepatitis B virus‑related hepatocellular carcinoma
by: Lihua Yu, et al.
Published: (2021-01-01)

Cannot write session to /tmp/vufind_sessions/sess_ld85min04jv23g7hkbkdk5tpo4